Mineralocorticoid receptor antagonist spironolactone prevents chronic corticosterone induced depression-like behavior
-
Add time:08/10/2019 Source:sciencedirect.com
SummaryHigh level of serum corticosteroid is frequently associated with depression, in which a notable HPA (hypothalamus-pituitary-adrenal) axis hyperactivity is often observed. There are two types of corticosteroid receptors expressed in the hippocampus that provide potent negative feedback regulation on the HPA axis but dysfunction during depression, i.e. the glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR). The balance between hippocampal MR and GR during chronic stress plays an important role in the occurrence of depression. The aim of this study is to explore if chronic corticosterone administration would induce depression-like behavior and affect the expression and function of hippocampal MR and GR, in addition to assess whether manipulation of corticosteroid receptors would modulate depressive behaviors. Hence, mice were treated with corticosterone (40 mg/kg) for 21 days followed by assessment in a battery of depression-like behaviors. The results show that chronic corticosterone-treated animals displayed an increased immobility time in a forced-swimming test, decreased preference to sucrose solution and novel object recognition performance, and enhanced hippocampal serotonin but decreased MR expression in both hippocampus and hypothalamus. On the other hand, co-administration of MR antagonist, spironolactone (25 mg/kg, i.p. × 7 days) in corticosteroid-treated animals reduced immobility time in a forced-swimming test and improved performance in a novel object recognition test. In conclusion, we demonstrate that chronic corticosterone treatment triggers several depression-like behaviors, and in parallel, down-regulates MR expression in the hippocampus and hypothalamus. Administration of an MR antagonist confers an anti-depressant effect in chronic corticosterone-treated animals.
We also recommend Trading Suppliers and Manufacturers of CORTICOSTERONE 21-SULFATE POTASSIUM (cas 100775-23-3). Pls Click Website Link as below: cas 100775-23-3 suppliers
Prev:The importance of corticosterone in mediating restraint-induced weight loss in rats
Next:Aldosterone 21-sulphate in man) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Central neural distribution of immunoreactive Fos and CRH in relation to plasma ACTH and corticosterone during sepsis in the rat08/16/2019
- Flesinoxan treatment reduces 5-HT1A receptor mRNA in the dentate gyrus independently of high plasma corticosterone levels08/15/2019
- Corticosterone-Induced Inhibition of Gliogenesis in Rat Hippocampus is Counteracted by Electroconvulsive Seizures08/14/2019
- The varying effects of short-term and long-term corticosterone injections on depression-like behavior in mice08/13/2019
- Abnormal response to stress and impaired NPS-induced hyperlocomotion, anxiolytic effect and corticosterone increase in mice lacking NPSR108/12/2019
- Aldosterone 21-sulphate in man08/11/2019
- The importance of corticosterone in mediating restraint-induced weight loss in rats08/09/2019


